Cisplatin Dose-intensity in Testicular Cancer Treatment: Analysis of a Randomized Clinical Trial

作者: Craig R Nichols , Stephen D Williams , Patrick J Loehrer , Lawrence H Einhorn , None

DOI: 10.1007/978-1-4899-0738-7_38

关键词:

摘要: The hypothesis that larger dose-time quotients of chemotherapy result in improved therapeutic outcome is firmly fixed modern oncologic thought and practice. This has enjoyed currency not only for the intuitive “rightness” concept, but based on results carefully conducted retrospective analysis clinical trials which often demonstrate superior patients receiving more dose-intensive treatments. Unfortunately, there are a handful randomized prospective adequately testing this hypothesis.

参考文章(18)
Kathleen N.S. Cathcart, Sylvia A. Holden, Emil Frei, Yenyun Wang, Beverly A. Teicher, Preclinical studies and clinical correlation of the effect of alkylating dose. Cancer Research. ,vol. 48, pp. 6417- 6423 ,(1988)
R F Ozols, D C Ihde, W M Linehan, J Jacob, Y Ostchega, R C Young, A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors. Journal of Clinical Oncology. ,vol. 6, pp. 1031- 1040 ,(1988) , 10.1200/JCO.1988.6.6.1031
Craig R Nichols, Guido Tricot, Stephen D Williams, Koen van Besien, Patrick J Loehrer, Bruce J Roth, Luke Akard, Ron Hoffman, Robert Goulet, Steven N Wolff, None, Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. Journal of Clinical Oncology. ,vol. 7, pp. 932- 939 ,(1989) , 10.1200/JCO.1989.7.7.932
G N Hortobagyi, G P Bodey, A U Buzdar, D Frye, S S Legha, R Malik, T L Smith, G R Blumenschein, H Y Yap, V Rodriguez, Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study. Journal of Clinical Oncology. ,vol. 5, pp. 354- 364 ,(1987) , 10.1200/JCO.1987.5.3.354
W Hryniuk, H Bush, The importance of dose intensity in chemotherapy of metastatic breast cancer. Journal of Clinical Oncology. ,vol. 2, pp. 1281- 1288 ,(1984) , 10.1200/JCO.1984.2.11.1281
Kenneth R. Hande, Robert K. Oldham, Mehmet F. Fer, Ronald L. Richardson, F. Anthony Greco, Randomized study of high-dose versus low-dose methotrexate in the treatment of extensive small cell lung cancer The American Journal of Medicine. ,vol. 73, pp. 413- 419 ,(1982) , 10.1016/0002-9343(82)90745-8
ROBERT F. OZOLS, High-Dose Cisplatin in Hypertonic Saline Annals of Internal Medicine. ,vol. 100, pp. 19- 24 ,(1984) , 10.7326/0003-4819-100-1-19
Michael K. Samson, Saul E. Rivkin, Stephen E. Jones, John J. Costanzi, Albert F. Lobuglio, Ronald L. Stephens, Edmund A. Gehan, Glenn D. Cummings, Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study Cancer. ,vol. 53, pp. 1029- 1035 ,(1984) , 10.1002/1097-0142(19840301)53:5<1029::AID-CNCR2820530503>3.0.CO;2-Z
Gedske Daugaard, Mikael Rørth, High-dose cisplatin and VP-16 with bleomycin, in the management of advanced metastatic germ cell tumors. European Journal of Cancer and Clinical Oncology. ,vol. 22, pp. 477- 485 ,(1986) , 10.1016/0277-5379(86)90115-X